Vicarious Surgical - RBOT Market Cap to Net Assets Ratio

vicarioussurgical.com - graphic logo of issuer RBOT

Vicarious Surgical Inc. (RBOT) is building a high-tech VR surgery ecosystem where the implementation of proprietary robots and physician training make switching providers extremely costly. This price chart on GURU.Markets, which currently stands at 0.82, confirms the brand's status as a leading developer of miniature systems. The company is expanding the capabilities of its devices for various abdominal interventions, thereby reducing patient recovery times.

vicarioussurgical.com (RBOT) - Market Value to Book Value from 07/04/2022 to 03/07/2026
Manufactured product of Vicarious Surgical Inc.

Experienced investors utilize multiples to distinguish fundamentally sound assets from speculative ones. This ratio compares the market value of a business to its net assets, determining the size of the control premium. For Vicarious Surgical Inc. (RBOT), this premium reflects market expectations for the successful implementation of robotic systems in clinics. The price action of the market-to-book ratio visualizes investor confidence in the future commercialization of these technologies, where high values indicate a bet on intellectual capital.

Competing companies

DXCM (DexCom, Inc.) - Market Cap to Net Assets Ratio|PEN: Market Cap to Book Value Multiple|Market Cap to Net Assets Ratio NOVT|HAE (Haemonetics Corp) - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio INSP|PRCT (Procept) - Market Value to Book Value|Market Capitalization to Book Value Ratio CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Market-to-Book Ratio|INMD - Market Value to Book Value Ratio|Market Value to Book Value PMI (Picard Medical Corp)|SRDX: Market Capitalization to Book Value Ratio|Senseonics Holdings, Inc. (SENS) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc.|Tactile Systems Technology Inc. - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio SNWV|OM - Market-to-Book Ratio|Electromed - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio LENSAR Inc LNSR|RCEL: Market Cap to Net Assets Ratio|Profound Medical Corp. - Market Cap to Book Value Multiple|BDMD: Market Capitalization to Book Value Ratio|EDAP - Market Capitalization to Book Value|APYX (Apyx Medical Corp) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Market Cap to Net Assets Ratio LUNG (Pulmonx Corporation)|TELA (telabio.com) - Market Value to Book Value|Market Value to Book Value Ratio CytoSorbents Corporation CTSO|SRTS - Market Cap to Net Assets Ratio|Zynex Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio electroCore, Inc.|IINN: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ICU|IRIX (IRIDEX Corp) - Market Capitalization to Book Value Ratio|Intelligent Bio (INBS) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio XAIR|Market Cap to Net Assets Ratio Profusa, Inc PFSA|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|Market Capitalization to Book Value Ratio GlucoTrack Inc. GCTK|NAOV - Market Value to Book Value Ratio|VERO: Market Value to Book Value Ratio|NUWE (CHF Solutions) - Market Cap to Net Assets Ratio|Aethlon Medical Corp - Market Value to Book Value|ASXC (Asensus Surgical Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio avinger.com AVGR|Market Value to Book Value Ratio biosig.com (BSGM)|Cutera Inc. (CUTR) - Market Value to Equity Ratio|Know Labs Corp - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Nevro Corp. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Market Value to Book Value Ratio